Search for: "Ventana Medical Systems Inc"
Results 1 - 11
of 11
Sorted by Relevance
|
Sort by Date
14 Nov 2007, 9:07 pm
By Donald Zuhn -- Last summer, we reported that Roche had made an offer to acquire Ventana Medical Systems, Inc. for $75 per share, or approximately $3 billion. [read post]
27 Jun 2007, 9:01 pm
By Donald Zuhn -- As we reported yesterday, Roche announced on Monday that it had made an offer to acquire Ventana Medical Systems, Inc. for $75 per share, or approximately $3 billion. [read post]
10 Jul 2007, 8:17 pm
By Donald Zuhn -- As we reported two weeks ago, Roche commenced a cash tender offer on June 27, 2007 to acquire all outstanding shares of Ventana Medical Systems, Inc. common stock. [read post]
26 Jun 2007, 9:50 pm
By Donald Zuhn -- On Monday, Roche announced that it had made an offer to acquire Ventana Medical Systems, Inc. for $75 per share, or approximately $3 billion. [read post]
11 Jul 2007, 9:43 pm
By Donald Zuhn -- As we reported two weeks ago, Roche commenced a cash tender offer on June 27, 2007 to acquire all outstanding shares of Ventana Medical Systems, Inc. common stock. [read post]
29 Dec 2006, 12:58 pm
On Dec. 29, the CAFC overturned a lower court's finding that rival BioGenex Laboratories Inc. had not infringed on a patent held by Ventana Medical Systems Inc. [read post]
28 Aug 2007, 3:50 pm
A federal district court in Arizona has preliminarily enjoined the enforcement of the Arizona business combination statute and control share statute with respect to Roche Holding AG's hostile bid for Ventana Medical Systems Inc. [read post]
26 May 2016, 8:59 pm
Ventana Medical Systems, Inc. v. [read post]
1 Jan 2007, 6:22 pm
December 29, 2006: Ventana Medical Systems, Inc. v. [read post]
23 May 2008, 1:03 am
– UAE, Nigeria, Ghana, Gambia and Tunisia draft resolution on counterfeiting: (KEI), Users raise Madrid System questions: (Managing Intellectual Property), How to build brands globally: (Managing Intellectual Property), Profile: Rhonda Steele, INTA President: (Managing Intellectual Property), Securitisation and coexistence agreements: (IP finance), Get your money’s worth in trade mark damages: (Managing Intellectual Property), Brand valuation: art or science? [read post]
25 Jan 2008, 1:00 am
: (Generic Pharmaceuticals & IP),Arava (Leflunomide) - Sanofi-Aventis loses bid to dismiss Louisiana Wholsesale Drug Co's antitrust claims accusing S-A of unlawfully blocking generic competition for Arava by filing a sham Citizen Petition with the USFDA: (IP Law360),Ciprofloxacin - CIPLA issued notice by National Pharmaceutical Pricing Authority for allegedly overpricing its antibiotic Ciprofloxacin (especially of note because CIPLA is objecting… [read post]
